KRM Ayurveda SME IPO GMP Today
KRM Ayurveda SME IPO opens on 21 January 2026. KRM Ayurveda SME IPO GMP is Rs 23.00 today. Listing price estimate is Rs 158.00 (issue price Rs 135.00). Listing gain estimate: 17.04%.
Issue Price
Rs 135.00
GMP Today
Rs 23.00
GMP %
+17.04%
Listing Price
Rs 158.00
Listing Gain / Lot
Rs 46,000.00
Listing Date
29 Jan 2026
KRM Ayurveda SME IPO GMP Day Wise
GMP for KRM Ayurveda SME started at Rs 0 on 14 January 2026 and stood at Rs 17 on 25 January 2026. The sharpest single-day jump was from Rs 0 on 14 Jan 2026 to Rs 15 on 15 Jan 2026. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike.
| Date | Issue Price | GMP | Listing Price | Estimated Profit |
|---|---|---|---|---|
| 25 Jan 2026Today | Rs 135.00 | Rs 17.00 | Rs 152.00 (+12.59%) | Rs 34,000.00 |
| 24 Jan 2026 | Rs 135.00 | Rs 17.00 | Rs 152.00 (+12.59%) | Rs 34,000.00 |
| 23 Jan 2026 | Rs 135.00 | Rs 17.00 | Rs 152.00 (+12.59%) | Rs 34,000.00 |
| 22 Jan 2026 | Rs 135.00 | Rs 16.00 | Rs 151.00 (+11.85%) | Rs 32,000.00 |
| 21 Jan 2026 | Rs 135.00 | Rs 12.00 | Rs 147.00 (+8.89%) | Rs 24,000.00 |
| 20 Jan 2026 | Rs 135.00 | Rs 21.00 | Rs 156.00 (+15.56%) | Rs 42,000.00 |
| 19 Jan 2026 | Rs 135.00 | Rs 20.00 | Rs 155.00 (+14.81%) | Rs 40,000.00 |
| 18 Jan 2026 | Rs 135.00 | Rs 20.00 | Rs 155.00 (+14.81%) | Rs 40,000.00 |
| 17 Jan 2026 | Rs 135.00 | Rs 20.00 | Rs 155.00 (+14.81%) | Rs 40,000.00 |
| 16 Jan 2026 | Rs 135.00 | Rs 18.00 | Rs 153.00 (+13.33%) | Rs 36,000.00 |
| 15 Jan 2026 | Rs 135.00 | Rs 15.00 | Rs 150.00 (+11.11%) | Rs 30,000.00 |
| 14 Jan 2026 | Rs 135.00 | Rs 0.00 | Rs 135.00 (+0.00%) | Rs 0.00 |
KRM Ayurveda SME IPO Listing Price
Based on today's GMP, KRM Ayurveda SME IPO listing price estimate is Rs 158.00 per share (issue price Rs 135.00 + GMP Rs 23.00).
Actual listing price will be known on 29 January 2026 when the stock lists on NSE/BSE.
KRM Ayurveda SME IPO Listing Gain
Lot size: 1000 shares (min. 2 lots for SME)
GMP today: Rs 23.00
Estimated listing gain per lot: Rs 23.00 × 2000 = Rs 46,000.00
GMP at roughly 17.0% suggests solid informal demand. The grey market expects the stock to list noticeably above the issue price.
GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.
GMP is unofficial. Listing gain can differ on listing day.
KRM Ayurveda SME IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for KRM Ayurveda SME is 72.48x. Compare this with the GMP trend to see if demand aligns. The GMP move around 15 Jan 2026 may reflect how the market reacted once the subscription window activity picked up after 21 Jan 2026.
See live figures on the KRM Ayurveda SME IPO Subscription Status page.
KRM Ayurveda SME IPO Details
| Field | Value |
|---|---|
| Price Band | ₹128.0 - ₹135.0 |
| Issue Size | ₹71.77 Cr |
| Lot Size | 1000 shares |
| IPO Type | NSE SME |
| Open Date | 21 Jan 2026 |
| Close Date | 23 Jan 2026 |
| Listing Date | 29 Jan 2026 |
| Subscription | 72.48x |
KRM Ayurveda SME IPO full details (financials, peers, review).
About KRM Ayurveda SME
No company information available
KRM Ayurveda SME IPO GMP FAQs
What is KRM Ayurveda SME IPO GMP today?
KRM Ayurveda SME IPO GMP is ₹23 as of 20 July 2026, 1:17 PM IST. At issue price ₹135, that is +17.04% expected listing gain in the grey market.
What is KRM Ayurveda SME IPO grey market premium (GMP)?
The grey market premium (GMP) for KRM Ayurveda SME IPO is ₹23 today. GMP is the unofficial premium traders pay above the issue price of ₹135 before listing on NSE/BSE.
What is KRM Ayurveda SME IPO expected returns?
KRM Ayurveda SME IPO expected returns based on today's GMP are +17.04% over the issue price of ₹135. Estimated listing price is ₹158 per share. Actual listing gain on 29 January 2026 may differ.
What is the estimated listing price of KRM Ayurveda SME IPO?
Based on today's GMP, KRM Ayurveda SME IPO estimated listing price is ₹158 per share (issue price ₹135 + GMP ₹23). The actual listing price will be set on 29 January 2026 when trading starts.
What is the expected profit per lot in KRM Ayurveda SME IPO?
At GMP of ₹23 and lot size of 1000 shares (minimum 2 lots for SME), estimated grey market profit is ₹46,000 (2 lot × 1000 shares × ₹23). This is unofficial and not guaranteed on listing day.
Will KRM Ayurveda SME IPO list at GMP price?
KRM Ayurveda SME IPO may list around ₹158 based on current GMP of ₹23, but listing at exact grey market price is not guaranteed. GMP is unofficial. On 29 January 2026, the opening price depends on market sentiment, final subscription, and index levels.
What is KRM Ayurveda SME IPO issue price and lot size?
KRM Ayurveda SME IPO issue price is ₹135 per share (price band ₹128.0 - ₹135.0). Lot size is 1000 shares. Minimum application is 2 lots for SME.
When is KRM Ayurveda SME IPO listing date?
KRM Ayurveda SME IPO listing date is 29 January 2026. The stock is expected to list on NSE and BSE on that day. GMP can change until listing.
What is KRM Ayurveda SME IPO GMP high and low?
KRM Ayurveda SME IPO GMP made a high of ₹21 on 20 Jan 2026 and a low of ₹0 on 14 Jan 2026 in tracked grey market data.
Can KRM Ayurveda SME IPO GMP change after subscription closes?
Yes. KRM Ayurveda SME IPO closed on 23 January 2026. GMP often moves between the close date and listing date (29 January 2026) based on allotment buzz, market mood, and news. Check this page for the latest GMP before listing.
What is KRM Ayurveda SME IPO subscription status?
Live category-wise subscription for KRM Ayurveda SME IPO is on the KRM Ayurveda SME IPO Subscription Status page on IPOwiz, including QIB, NII, and retail figures.
How to check KRM Ayurveda SME IPO allotment status?
Allotment for KRM Ayurveda SME IPO can be checked on the KRM Ayurveda SME IPO Allotment Status page on IPOwiz, on the registrar website, BSE allotment page, or the IPOwiz App using your PAN.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. GMP verified before publish.